A detailed history of Colonial Trust CO / Sc transactions in Novo Nordisk A S stock. As of the latest transaction made, Colonial Trust CO / Sc holds 2,457 shares of NVO stock, worth $289,360. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,457
Previous 2,457 -0.0%
Holding current value
$289,360
Previous $315,000 11.11%
% of portfolio
0.06%
Previous 0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$102.11 - $135.92 $4,799 - $6,388
-47 Reduced 1.88%
2,457 $315,000
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $85,673 - $102,919
976 Added 63.87%
2,504 $259,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $47,106 - $103,361
518 Added 51.29%
1,528 $138,000
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $111,369 - $123,272
714 Added 241.22%
1,010 $163,000
Q1 2023

May 11, 2023

SELL
$132.34 - $159.14 $926 - $1,113
-7 Reduced 2.31%
296 $47,000
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $31,072 - $41,004
303 New
303 $41,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $266B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Colonial Trust CO / Sc Portfolio

Follow Colonial Trust CO / Sc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust CO / Sc, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust CO / Sc with notifications on news.